SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) — Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its BioXp Select DNA Cloning kit. The BioXp Select DNA Cloning kit enables on-demand and automated assembly of DNA fragments via…Read More